Trial intelligence / Profile preview

Kytril for PONV Prevention in Pediatric Tonsillectomy

NCT00231478Phase 4Completed

Sponsor
Roche
Start
Apr 2007
Primary completion
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of granisetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Roche. Primary endpoint: Number of Patients With no Vomiting. Started Apr 2007; status: completed.

02

Drugs

granisetron
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT00231478.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00231478.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call